Comparison of Wistar vs. Fischer rat in the incidence of 1,2-dimethylhydrazine induced intestinal tumors

Radiology and Oncology

Volumn 38, Issue 3, 2004, Pages

  Večerić, Željka ^a,b   Cerar, Anton ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b NONE   (Slovenia)

Author keywords

1,2 dimethylhydrazine; Inbred F344; Intestinal neoplasms chemically induced; Rats; Rats Wistar

Indexed keywords

1,2 DIMETHYLHYDRAZINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; BENIGN TUMOR; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER SUSCEPTIBILITY; CARCINOGENESIS; COLON ADENOMA; COLON CARCINOMA; COLORECTAL CANCER; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG DOSAGE FORM; HISTOLOGY; INTESTINE TUMOR; MALIGNANT NEOPLASTIC DISEASE; MUCINOUS CARCINOMA; NONHUMAN; RAT; RAT STRAIN; SIGNET RING CARCINOMA; STATISTICAL ANALYSIS; STRAIN DIFFERENCE;

EID: 19644373339     PISSN: 13182099     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Boring CC, Sqires TS, Tong T, Montgomery S. Cancer statistics. CA Cancer J Clin 1994; 44: 9.
2. Register raka za Slovenijo. Incidenca raka v Sloveniji. Ljubljana: Onkološki inštitut v Ljubljani, 1994: 13.
3. Ishiguro Y, Ochinai M, Sugimura T, Nagao M, Nakagama H. Strain differences of rats in the susceptibility to aberrant crypt foci formation by 2-amino-1-metyl-6-phenylimidazo-[4,5-b]pyridine: no implication of Apc and Pla2g2a genetic polymorphisms in differential susceptibility. Carcinogenesis 1999; 20(6): 1063-8.
4. Evans JT, Hauschka TS, Mittelman A. Differential susceptibility of four mouse stains to induction of multiple large-bowel neoplasms by 1,2-dymethylhydrazine. J Natl Cancer I 1974; 52: 999-1000.
5. Melhem MF, Kunz HW, Gill TD. Genetic control of susceptibility to diethylnitrosamine and dimethylbenzanthracene carcinogenesis in rats. Am J Pathol 1991; 139: 45-51.
6. Teague CA, Gavin JB, Heridson PB. The response of three inbred strains of rat to the cancerogen 1,2-dimethylhydrazine. Pathology 1981; 13: 473-85.
7. Evans JT, Shows TB, Sproul EE, Paolini NS, Mittelman A, Hauschka TS. Genetics of colon carcinogenesis in mice treated with 1,2-dimethylhydrazine. Cancer Res 1977; 37: 134-40.
8. Breskvar L, Cerar A. A role of gender in the occurence of dimethylhydrazine induced colorectal tumors in Wistar rats. Radial Oncol 1997; 31: 374-9.
9. Martin MS. Experimental intestinal carcinogenesis. Cancer 1992; 5: 1-10.
10. Shamsuddin AKM. Carcinoma of the large intestine: animal models and human disease. Hum Pathol 1986; 17: 451-3.
11. Dukes C. The classification of cancer of the rectum. J Pathol Bacterial 1932; 35: 313-32.
12. Toth B. Synthetic and naturally occuring hydrazines as possible cancer causative agents. Cancer Res 1975; 35: 3693-7.
13. Fiala ES. Investigations into the metabolism and mode of action of the colon carcinogens 1,2-di-methylhydrazine and azoxymethane. Cancer 1977; 40: 2436-45.
14. Fiala ES, Bobotas G, Kulakis C, Wattenberg LW, Weisburger H. Effects of disulfiram and related compounds on the metabolism in vivo of the colon carcinogen 1,2-dimethylhydrazine. Biochem Pharmacol 1977; 26: 1763-8.
15. Fiala ES, Sthathopoulos C. Metabolism of methylazoxymethanol acetate in the F344 rat and strain-2 guinea pig and its inhibition by pyrazole and disulfiram. J Cancer Res Clin Oncol 1984; 108: 129-34.
16. Swenberg JA, Cooper HK, Bucheler J, Kleihues P. 1,2-dimethylhydrazine- induced methylation of DNA bases in various rat organs and the effect of pretreatment with disulfiram. Cancer Res 1979; 39: 465-7.
17. Zedeck MS, Stemberg SS, Pynter RW, McGowan J. Biochemical and pathological effects of methylazoxymethanolacetate, a potent carcinogen. Cancer Res 1970; 30: 801-12.
18. Fiala ES, Kulakis C, Christiansen G, Weisburger JH. Inhibition of the metabolism of the colon carcinogen, azoxymethane by pyrazole. Cancer Res 1978; 38: 4515-21.
19. Fiala ES, Caswell N, Sohn OS, Felder MR, McCoy D, Weisburger JH. Non-alcohol dehydrogenase-mediated metabolism of methylazoxymethanol in the deer mouse Peromyscus maniculatus. Cancer Res 1984; 44: 2885-91.
20. Day DW. The adenoma-carcinoma sequence. Scand J Gastroenterol 1984; 19(Suppl 104): 99-107.
21. Hill MJ, Morson BC, Bussey HJR. Aetiology of adenoma-carcinoma sequence in large bowel. Lancet 1978; i: 245-7.
22. Sunter JP. Cell proliferation in gastrointestinal carcinogenesis. Scand J Gastroenterol 1984; 19(Suppl 104): 45-9.
23. Newberne PM, Rogers AE. Adenocarcinoma of the colon. Am J Pathol 1988; 72: 541-4.
24. Hagihara PF, Yoneda K, Sachattelo CR, Hedgecock H, Flesher JV, Ram MD, Griffen WO, Goldenberg DM. Colonic tumorigenesis in rats with 1,2-DMH: Dis Colon Rectum 1980; 23: 137-40.
25. Maskens AP. Histogenesis and growth pattern of 1,2-dimethylhydrazine- induced rat colon adenocarcinoma. Cancer Res 1978; 36: 1585-92.
26. Lipkin M, Deschner E. Early proliferative changes in intestinal cells. Cancer Res 1976; 36: 2665-8.
27. Rubio CA, Nylander G, Sveander M, Duvander A, Alun ML. Minimal invasive carcinoma of the colon in rats. Am J Pathol 1986; 123: 161-5.
28. Park HS, Goodland RA, Wright NA. The incidence of aberrant crypt foci and colonic carcinoma in dimethylhydrazine-treated rats varies in a site-specific manner and depends on tumor histology. Cancer Res 1997; 57(20): 4507-10.
29. Hardman WE, Cameron IL. Colonic crypts located over lymphoid nodules of 1,2-dimethylhydrazine-treated rats are hyperplastic and at high risk of forming adenocarcinomas. Carcinogenesis 1994; 15(10): 2353-61.